Buy & Sell Costco Wholesale Corporation (COST) – Costco Wholesale Corporation Price Today
Aura AI Summary
Key Stats
- $456.18BMarket Cap
- Consumer StaplesSector
- -6.04%3M Drawdown
- $446.11BEnterprise Value
- 0.57%Dividend Yield
- 123 daysTypical Hold Time
Costco Wholesale Corporation (COST) is currently valued at a market capitalization of $456.18B, with an enterprise value of $446.11B. Over the past 52 weeks, Costco Wholesale Corporation has traded between a low of $849.63 and a high of $1,094.32, highlighting its annual price range. Over the past three months, Costco Wholesale Corporation has recorded a drawdown of -6.04%, reflecting recent price volatility. Costco Wholesale Corporation offers a dividend yield of 0.57%, with the most recent dividend of $1.47 paid on 01 May 26. On average, investors hold Costco Wholesale Corporation for approximately 123 days, indicating typical investor behavior on the platform.
About Costco Wholesale Corporation
The leading warehouse club, Costco has 815 stores worldwide (at the end of fiscal 2021), with most sales derived in the United States (72%) and Canada (14%). It sells memberships that allow customers to shop in its warehouses, which feature low prices on a limited product assortment. Costco mainly caters to individual shoppers, but roughly 20% of paid members carry business memberships. Food and sundries accounted for 40% of fiscal 2021 sales, with non-food merchandise 29%, warehouse ancillary and other businesses (such as fuel and pharmacy) nearly 17%, and fresh food 14%. Costco's warehouses average around 146,000 square feet
Most Recent News
Bempedoic acid shows promise in lowering LDL-C in children and statin-intolerant adults, per Esperion data.
Esperion Therapeutics presented new data at the 2026 European Atherosclerosis Society Congress showing bempedoic acid effectively lowers LDL cholesterol in children aged 6-17 with familial hypercholesterolemia and is well tolerated. A secondary analy...

Rhythm Pharmaceuticals to present at major healthcare conferences in June 2026
Rhythm Pharmaceuticals announced that its CEO and CFO will participate in fireside chats at the Jefferies Global Healthcare Conference on June 4 and the Goldman Sachs Global Healthcare Conference on June 8, 2026. These events will be webcast and acce...

Virax Biolabs reports positive early data for ViraxImmune™, a test for Long COVID and related syndromes.
Virax Biolabs announced encouraging early pilot data for ViraxImmune™, a blood test in development to detect Long COVID, ME/CFS, and related post-acute infection syndromes. The test showed 88% specificity and 92% positive predictive value in distingu...
